Quick Takeaways
- Medtronic plc filed SCHEDULE 13G/A for Orchestra BioMed Holdings, Inc. Common Stock, Par Value $0.0001 Per Share (OBIO).
- Disclosed ownership: 15%.
- Date of event: 31 Dec 2024.
Medtronic plc - 31 Dec 2024 SCHEDULE 13G/A Report for Orchestra BioMed Holdings, Inc. Common Stock, Par Value $0.0001 Per Share (OBIO)
- Filing Manager
- Medtronic plc
- Reporting Manager
- Medtronic plc
- Symbol
- OBIO
- Shares outstanding
- 38,109,844 shares
- Disclosed Ownership
- 5,868,916 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:06:04 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 27 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Medtronic plc disclosed 15% ownership in Orchestra BioMed Holdings, Inc. Common Stock, Par Value $0.0001 Per Share (OBIO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 15% | 5,868,916 | 0 | 5,868,916 | /s/ Tom Osteraas | Assistant Secretary and Legal Director | |
| Covidien Group S.a.r.l. | 15% | 5,868,916 | 0 | 5,868,916 | /s/ Salvador Sens | General Manager |